Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.08 -0.03 (-1.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Convertible Debt (2023 - 2024)

Updated

Ernexa Therapeutics' Convertible Debt came in at $32.04 million for Q3 2024, up 828.1% from $3.45 million a year earlier and up 260.2% from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Convertible Debt (2023 - 2024) Analysis & Trends

At the end of FY2023, Ernexa Therapeutics' Convertible Debt was $6.77 million.

  • Business Quant data shows ERNA's Convertible Debt at $8.9 million (Q2 2024), $8.01 million (Q1 2024) and $6.77 million (Q4 2023) in the three quarters before Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Ernexa Therapeutics 2.43 Mn -16.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 32.04 Mn
Jun 30, 2024 8.90 Mn
Mar 31, 2024 8.01 Mn
Dec 31, 2023 6.77 Mn
Sep 30, 2023 3.45 Mn
API Access

Ernexa Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ERNA&period=max&api_key=YOUR_API_KEY